State Food and Drug Administration: Encourage innovative medical device research and development

According to CCTV News on the 2nd, according to CCTV News on the 2nd, it was learned from the State Food and Drug Administration that in order to encourage the research and development of innovative medical devices, the State Food and Drug Administration has set up a special channel to accelerate the development of intellectual property rights in China, which is at the international advanced level. Innovative medical devices with significant clinical application value, as well as national key scientific and technological projects, supported by national key research and development programs, and clinical trials conducted by the National Clinical Medical Research Center and approved by the central management department are given priority evaluation.

In accordance with the early intervention, the responsibility of the person, the principle of scientific approval, standard Without reducing, the program is not reduced, for innovation medical instruments Priority approval projects will be given priority in the technical review process. By opening remote video reviews, the exchanges and interactions between experts, reviewers and applicants will be increased. In addition, in order to gradually realize the evaluation of clinical evaluations. The evaluation is in line with international standards, and the acceptance principle of clinical trial data obtained abroad is reported in China, and the overseas medical devices are simultaneously listed in China and the world.